Archives aisling-capital

by in
Entry Author Date Location
Good Times Roll on for Biotech VCs As Clarus Bags New $500M Fund 06/09/15 Boston
Spirox Inhales $18.5M to Advance Nasal Surgery Device 04/21/15 San Francisco
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More 03/13/15 San Francisco
Allergen Takes $80M Series B for Phase 3 Peanut Allergy Trial 03/12/15 San Francisco
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
Cidara’s $42M Series B May Bring Fungal Therapy to Patients 02/11/15 San Diego
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
As Atlas Splits, Is There A Case To Make In Venture For Specialists? 10/22/14 National
T2 Biosystems Sputters Through IPO Queue, Raises $57M 08/07/14 Boston
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma 07/02/14 San Diego
With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara 06/30/14 San Diego
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Versartis Lands $55,000,000 Series E Financing 02/18/14 San Francisco
Miramar Labs Secures $10,000,000 Series D Funding 02/13/14 San Francisco
ViewRay Lands $30,000,000 New Funding 12/17/13 Detroit
ViewRay Secures $30,000,000 New Financing 12/17/13 Detroit
Seragon Pharmaceuticals Obtains $30,000,000 Series A Financing 10/18/13 San Diego
Versartis Garners $20,000,000 Series D Financing Round 10/08/13 San Francisco
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Loxo Oncology Lands $33,000,000 Series A Funding Round 10/04/13 New York
5 Things Biotechs Should Do to Take Advantage of The Boom 09/05/13 New York
Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing 08/16/13 Boston
Esperion Therapeutics Secures $33,000,000 New Funding Round 04/25/13 Detroit
T2 Biosystems Obtains $40,000,000 Series E Funding 03/28/13 Boston
Versartis Secures $25,000,000 Series C Funding 01/15/13 San Francisco
Mayleben Ends Short-Lived Retirement to Lead Esperion 01/04/13 Detroit
San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit 11/09/12 San Diego
San Diego’s Ambit Biosciences Raises $25M to Advance Leukemia Drug 11/06/12 San Diego
Page 1 of 3 next page »